Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

DuPont Names de Andrade to Biotechnology Advisory Panel

By Pharmaceutical Processing | November 2, 2004

WILMINGTON, DE (November 2, 2004) – DuPont this week announced the addition of Dr. Marcelo Carvalho de Andrade to its external Biotechnology Advisory Panel. Dr. de Andrade is the founder and chairperson of Pro-Natura, an international non-governmental organization specializing in sustainable development.

He joins the ranks of six other panel members to bring viewpoints to the broad area of biotechnology and its application in agriculture, food and bio-based materials.

Established in 2000, the DuPont panel is an independent body charged with providing counsel to guide DuPont’s actions, help create positions on issues, as well as challenge the organization in the development, testing and commercialization of new productsbased on biotechnology, the company said.

“Dr. de Andrade’s significant and long-term involvement in the sustainable development movement in South America and around the globe will prove invaluable as we continue to work toward achieving business sustainability goals,” Charles O. Holliday, Jr., DuPont’s chairman and chief executive officer, said. “His expertise and global perspective, as well as those of our other panel members, is an asset to our decision-making process as we bring new products to market.”

According to DuPont, Dr. de Andrade is an ardent advocate for sustainable community development and has been committed to biodiversity conservation, environmentalpreservation and restoration and improving the quality of life.

He is currently a member of a private-sector advisory panel for the Brazilian government.

The work of DuPont’s external Biotechnology Advisory Panel is facilitated by the Keystone Center, a non-profit organization based in Keystone, CO, which includes a regular audit of DuPont’s progress in the biotechnology arena.

DuPont was founded in 1802 and operates in more than 70 countries, offering awide range of products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE